Sign in
4

Changes in Ownership

Organon & Co. Filed Acc 0000899243-21-033670

Options or other derivatives

  • Chief Financial Officer acquired 44,642 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WALSH MATTHEW M · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-08-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +44,642 $35.38 2031-08-16 44,642 44,642 D
Loading xslF345X03/doc4.xml…